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Abstract: Comparable data on trends of hospitalization rates for ST-
segment elevation myocardial infarction (STEMI) and non-STEMI
(NSTEMI) remain unavailable in representative Asian populations.
To examine the temporal trends of hospitalization for acute myo-
cardial infarction (AMI) and its subtypes in Beijing.
Patients hospitalized for AMI in Beijing from January 1, 2007 to
December 31, 2012 were identified from the validated Hospital Dis-
charge Information System. Trends in hospitalization rates, in-hospital
mortality, length of stay (LOS), and hospitalization costs were analyzed
by regression models for total AMI and for STEMI and NSTEMI
separately. In total, 77,943 patients were admitted for AMI in Beijing
during the 6 years, among whom 67.5% were males and 62.4% had
STEMI. During the period, the rate of AMI hospitalization per 100,000
population increased by 31.2% (from 55.8 to 73.3 per 100,000 popu-
lation) after age standardization, with a slight decrease in STEMI but a
3-fold increase in NSTEMI. The ratio of STEMI to NSTEMI decreased
dramatically from 6.5:1.0 to 1.3:1.0. The age-standardized in-hospital
mortality decreased from 11.2% to 8.6%, with a significant decreasing
trend evident for STEMI in males and females (P<0.001) and for
NSTEMI in males (P¼0.02). The rate of percutaneous coronary
intervention increased from 28.7% to 55.6% among STEMI patients.
The total cost for AMI hospitalization increased by 56.8% after adjust-
ing for inflation, although the LOS decreased by 1 day.
The hospitalization burden for AMI has been increasing in Beijing
with a transition from STEMI to NSTEMI. Diverse temporal trends inie, MD, PhD, Xueq oning Guo, MS,
ru Liu, MS, and Jing Liu, MD, PhD
(Medicine 95(5):e2677)
Abbreviations: AMI = acute myocardial infarction, CABG =
coronary artery bypass graft, CHD = coronary heart disease, HDIS
= Hospital Discharge Information System, ICD-10 = the
International Classification of Diseases 10th Revision, ICD-9-
CM-3 = International Classification of Diseases Clinical
Modification of 9th Revision Operations and Procedures, LOS =
length of stay, NSTEMI = non-ST-segment elevation myocardial
infarction, PCI = percutaneous coronary intervention, STEMI = ST-
segment elevation myocardial infarction.
INTRODUCTION
C oronary heart disease (CHD) is the leading cause of deathworldwide.1 Acute myocardial infarction (AMI) represents
a serious clinical manifestation of CHD and is associated with
high mortality, especially during hospitalization in the acute
phase.2 Therefore, information on trends of hospitalization for
AMI is of considerable value to health-policy makers, hospital
administrators, clinicians, and researchers.
Routinely collected data on hospital discharges in the
United States and Europe have indicated declining trends of
hospitalization rates for AMI, with a shift away from ST-
segment elevation myocardial infarction (STEMI) toward rising
rates of non-STEMI (NSTEMI).3–5 STEMI and NSTEMI are 2
major subtypes of AMI representing markedly different treat-
ment options and outcomes. Unlike the dominance of NSTEMI
in Western countries, STEMI accounts for 60% to 80% of AMI
in Asians.6–8 A declining proportion of STEMI accompanied by
an increasing proportion of NSTEMI was recently observed in a
hospital-based registry study in Korea.8 However, to the best of
our knowledge, comparable data on trends of hospitalization
rates for STEMI and NSTEMI remain unavailable in represen-
tative Asian populations.
Beijing, the capital of China and home to more than 19.61
million people, is characterized by aWestern lifestyle, and leads
the increasing trends in the incidence and mortality rates of
acute coronary events in China during the 1980s and 1990s
according to the Sino-MONICA (multinational monitoring of
trends and determinants in cardiovascular disease) project.9
Since the termination of the MONICA project, representative
data on temporal trends of coronary events, particularly nonfatal
events, are sparse in Beijing. The rapid development of the
health information system in the past decade in Beijing provides
an opportunity to monitor CHD morbidity and mortality basedadministrative data at the city level.10
n the validated data from the Beijing
ormation System (HDIS) from 2007 to
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2012, we examined the patient characteristics and temporal
trends of hospitalization for AMI and its subtypes in terms of
hospitalization rate, in-hospital mortality, length of stay (LOS),
and hospitalization costs.
METHODS
Data Sources
Data on the age-specific annual population of permanent
residents in Beijing for each year of interest were obtained from
the Beijing Municipal Bureau of Statistics. Data were obtained
from the Beijing HDIS, a system covering all secondary and
tertiary nonmilitary hospitals in Beijing. A total of 162 hospi-
tals, including both public and private hospitals, report hospital
discharge abstracts to the HDIS. Hospital admissions for AMI
from January 1, 2007 to December 31, 2012 among permanent
residents of Beijing were identified according to the principal
discharge diagnosis using the International Classification of
Diseases 10th revision (ICD-10) codes I21 (AMI) or I22
(subsequent AMI), and subtypes of AMI were further classified
(STEMI codes I21.0–I21.3, I22.0, I22.1, and I22.8; NSTEMI
code I21.4; unspecified AMI I21.9 and I22.9) by referring to
previous reports3,4 and our validation study (see Table 1,
supplemental content, http://links.lww.com/MD/A662, Concor-
dance of ICD code-based diagnoses/procedures in hospital
discharge information system with the clinical diagnoses/pro-
cedures in hospital charts). ICD-10 has been adopted in China
since 2002 and the codes for AMI have not been changed during
the study time period. Comorbidities were identified from
secondary discharge diagnoses (up to 7 diagnoses). Revasculari-
zation treatments were identified using codes from International
Classification of Diseases Clinical Modification of 9th Revision
Operations and Procedures (ICD-9-CM-3), with codes 00.66,
36.01, 36.02, 36.05, 36.06, and 36.07 for percutaneous coronary
intervention (PCI) and 36.1 for coronary artery bypass graft-
ing (CABG). ICD code-based diagnoses/procedures in the
HDIS were validated based on chart reviews (see Table 1
and Table 2, supplemental content, http://links.lww.com/MD/
A662, which illustrate concordance of ICD code-based diag-
noses/procedures in hospital discharge information system with
the clinical diagnoses/procedures in hospital charts and pre-
dictive value of ICD codes for AMI in hospital discharge
information system for clinical diagnosis of AMI defined by
MONICA Criteria or Third Universal Definition of Myocardial
Infarction respectively). Patients with a total LOS of1 day and
who were discharged alive were excluded (857 cases) because
they were unlikely to have had an AMI.11 Patients who
were discharged and then rehospitalized on the same day
(including transferred patients) were linked according to
personal identification information and considered a single
continuous episode of care (2272 cases). In total, 77,943
hospital admissions for AMI were included in the final analysis.
This project (contract No. 2011-1005-01) was funded by the
Beijing Health Bureau and approved by the Ethics Committee
of Beijing Anzhen Hospital.
Statistical Analysis
The hospitalization rate of AMI was defined as the number
of AMI hospitalizations for each age–sex category divided by
the corresponding population estimate and standardized to the
Zhang et al2000 Census population of Beijing. The in-hospital mortality of
AMI was calculated as the number of inpatients who died of
AMI for each age–sex category divided by the corresponding
2 | www.md-journal.comnumber of AMI hospitalizations and was standardized accord-
ing to the total of AMI admissions from 2007 to 2012. Trends in
hospitalization rates and in-hospital mortality rates throughout
the study period were tested using the Poisson regression and
adjusted for age and sex or age alone as needed.11 The LOS is
presented as the geometric means in days, given the skewed
distribution, and the temporal trends of LOS were estimated by
linear regression models after log-transformation.5 Similar
methods were used for the analysis of the temporal trends of
hospital cost per hospitalization. To facilitate direct compari-
sons between years for hospital costs, we converted all hospital
costs to 2012 Chinese Yuan RMB using the consumer price
index in China. All P values were 2-sided, with significance set
at P<0.05. Statistical analyses were performed using SAS
version 9.2 (SAS Institute Inc, Cary, NC).
RESULTS
Patient Characteristics
There were 77,943 hospital admissions for AMI in Beijing
from 2007 to 2012 (Figure 1). The mean age was 65.9 13.1
years, and 67.5% of patients were men. Female patients were 9
years older and more multimorbid than males (Table 1). The
proportion of STEMI was higher in males, while the opposite
was true for NSTEMI. Collectively, 62.4% of the AMI cases
were STEMI, 28.8% were NSTEMI, and 8.8% were unspeci-
fied. During the 6 years, the ratio of STEMI to NSTEMI
decreased dramatically from 6.5:1.0 in 2007 to 1.3:1.0 in
2012 (Figure 2). Compared with patients with STEMI, those
with NSTEMI were 4.9 years older (69.0 12.2 vs 64.1 13.2
yr) and more likely to have coexisting illnesses (Figure 3). The
proportion of PCI use increased from 28.7% to 55.6% over the 6
years in patients with STEMI, and from 22.7% to 30.0% in those
with NSTEMI (both P<0.001). The rate of CABG dropped
slightly from 2.7% to around 2% in patients with STEMI
(P¼ 0.04) and remained stable at around 3% in those with
NSTEMI throughout the study period (P¼ 0.65) (Figure 4).
Hospitalization Rates
During the 6 years, the AMI hospitalization rate per
100,000 population increased by 49.5% (from 80.5 to 120.4)
before and by 31.2% (from 55.8 to 73.3) after age standardiz-
ation with the greatest increase noted in the youngest age group
(<55 years) in both sexes (Table 2). Diverse trends were found
for subtypes of AMI, with a slight decrease in the rate of STEMI
but a three-fold increase in the rate of NSTEMI (Figure 5).
In-Hospital Mortality
In-hospital mortality was higher in women than men and
higher in STEMI than NSTEMI (Table 3). From 2007 to 2012,
the age-standardized in-hospital mortality decreased from
11.2% to 8.6%, with a significant decreasing trend evident
for STEMI in both males and females and for NSTEMI in
males. Regarding treatment, in-hospital mortality was lower for
patients receiving revascularization therapies, particularly those
undergoing PCI. During the 6 years, a significant decline in in-
hospital mortality was observed for male patients with STEMI
who underwent PCI (P¼0.01).
Length of Hospital Stay and In-Hospital Costs
Medicine  Volume 95, Number 5, February 2016The LOS was longer in women than in men and longer in
patients with NSTEMI than STEMI (see Table 3, supplemental
content, http://links.lww.com/MD/A662, which illustrates the
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Characteristics of Patients Hospitalized for AMI in Beijing by Sex, 2007 to 2012
2007 2008 2009 2010 2011 2012 2007–2012
Male
Number of patients 6613 7807 8977 9131 9639 10471 52638
Age, yr 63.1 13.3 62.8 13.2 62.6 13.3 62.9 13.4 63.2 13.4 63.4 13.5 63.0 13.3
Comorbidity (%)
Hypertension 50.0 45.5 43.8 41.7 43.9 41.5 44.0
Heart failure 43.7 45.0 47.2 44.4 40.5 37.5 42.8
Dyslipidemias 29.3 34.1 37.2 43.2 45.5 48.2 40.5
Diabetes 24.6 26.8 28.3 29.3 30.6 29.7 28.5
Pneumonia 13.5 14.7 14.8 15.3 14.4 12.9 14.2
Atrial fibrillation 6.1 6.2 6.7 7.0 7.6 7.8 7.0
Renal failure 4.4 4.7 5.7 5.5 6.7 7.3 5.8
Stroke 3.1 3.7 3.2 3.4 3.4 4.2 3.5
Subtypes (%)
STEMI 85.1 73.9 64.9 63.2 60.0 55.8 65.8
NSTEMI 11.6 20.9 23.9 26.9 30.3 36.2 26.1
Unspecified 3.2 5.2 11.2 9.9 9.7 7.9 8.2
Female
Number of patients 3151 3658 4265 4305 4775 5151 25305
Age, yr 71.5 9.8 71.6 10.1 71.8 10.0 71.9 10.1 72.1 10.2 72.6 10.5 72.0 10.1
Comorbidity (%)
Hypertension 62.3 66.3 68.5 70.3 68.8 69.0 67.9
Heart failure 49.8 53.2 57.2 56.2 53.1 52.2 53.7
Dyslipidemias 24.9 30.1 33.8 37.6 39.4 41.9 35.5
Diabetes 34.5 38.4 38.1 39.7 40.5 37.8 38.4
Pneumonia 20.9 22.7 23.4 24.9 22.1 21.5 22.6
Atrial fibrillation 8.3 10.9 10.9 11.3 11.9 13.0 11.2
Renal failure 5.0 6.5 7.6 7.9 9.0 9.5 7.8
Stroke 4.6 4.8 4.9 5.6 5.4 6.1 5.3
Subtypes (%)
STEMI 81.6 64.2 54.3 51.6 48.0 43.5 55.3
NSTEMI 15.8 29.6 31.9 36.0 40.1 45.5 34.6
Unspecified 2.6 6.2 13.8 12.4 11.8 11.0 10.1
Data are displayed as a percentage except age, which is presented as mean and standard deviation.
ele
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the period, the overall LOS was shortened by 0.9 day (from 10.6
to 9.7 days). Meanwhile, the in-hospital cost per hospitalization
for AMI increased by 3.2% after adjusting for inflation
(P<0.001), with a significant decrease achieved in PCI for
both STEMI and NSTEMI but an increase for CABG (see Table
4, supplemental content, http://links.lww.com/MD/A662,
which illustrate geometric means of hospital costs per hospi-
talization for patients with AMI in Beijing by sex, AMI subtype,
and type of intervention from 2007 to 2012). The cost of all AMI
CABG¼ coronary artery bypass grafting; NSTEMI¼ non-ST-segment
STEMI¼ST-segment elevation myocardial infarction.hospitalizations increased by 81.6% before (from 0.38 billion
RMB in 2007–0.69 billion RMB in 2012) and 56.8% after
adjusting for inflation throughout the study period.
DISCUSSION
Using a large database of an unselected hospitalized
patient population of AMI, we demonstrated a significant
increase in AMI hospitalization rates in Beijing with a rapid
change in the pattern of AMI subtypes: a marked rise in the rate
of NSTEMI accompanied by an underlying reduction in the rate
of STEMI. In-hospital mortality and LOS decreased, whereas
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.per-hospitalization and total in-hospital costs increased steadily.
This is, to our knowledge, the first study using validated ‘‘real-
world’’ data at the city level in China.
Unlike the decrease in the AMI hospitalization rate in
Western populations,4,11,12 our study found an overall increas-
ing trend of AMI hospitalization in Beijing, whereas the trend
varies greatly by subtypes of AMI. One notable finding was the
transition of the AMI subtypes from STEMI to NSTEMI in
Beijing, following earlier trends in Western populations.4,11,12
The hospitalization rate for NSTEMI exceeded that for STEMI
around the year 2005 in Germany3 and Ireland4 and in the 1990s
in the United States.2,13 Our findings indicate that this transition
is happening in Asian populations, among which STEMI has
been dominant.6,7 We found that the ratio of STEMI to
NSTEMI decreased dramatically from 6.5:1.0 in 2007 to
1.3:1.0 in 2012 and that the proportion of NSTEMI outpaced
STEMI in 2012 among females. Similarly, a proportional out-
weighing of NSTEMI to STEMI occurred in 2012 in the Korea
Acute Myocardial Infarction Registry.8 Another interesting
vation myocardial infarction; PCI¼ percutaneous coronary intervention;finding was the greatest increase in AMI hospitalization was
noted in the youngest age group (<55 years) in both sexes,
which was consistent with the high prevalence of cardiovascular
www.md-journal.com | 3
TABLE 2. Hospitalization Rate (per 100,000 Population) for Patients With Acute Myocardial Infarction (AMI) in Beijing by Sex,
Age, and AMI Subtype, 2007 to 2012
2007 2008 2009 2010 2011 2012
Relative Change
2007–2012,% P for Trend
Male
Age groups, yr
<55 42.2 50.3 58.1 58.9 60.3 61.5 45.8 <.001
55–64 217.3 259.3 284.5 273.1 279.4 306.1 40.9 <.001
65–74 376.2 401.2 440.0 435.9 423.1 451.7 20.1 <.001
75–84 523.4 563.2 608.8 592.0 616.0 600.2 14.7 <.001
85 460.2 534.6 509.1 542.0 536.3 618.7 34.4 <.001
Subtypes
STEMI

64.9 64.0 63.3 60.7 59.4 59.3 8.7 <.001
NSTEMI

8.1 16.4 20.9 23.9 26.2 33.5 311.8 <.001
Unspecified

2.5 4.2 10.1 8.5 8.8 7.1 187.8 <.001
Subtotal for male

75.5 84.7 94.2 93.1 94.4 99.9 32.3 <.001
Female
All age groups, yr
<55 4.1 5.2 6.0 5.9 6.7 6.8 67.8 <.001
55–64 64.2 76.2 81.7 80.4 78.8 82.7 28.8 <.001
65–74 247.8 255.7 292.8 278.2 297.2 296.7 19.7 <.001
75–84 417.2 463.6 514.2 493.2 539.9 537.3 28.8 <.001
85 331.7 394.7 412.4 462.8 420.9 532.8 60.6 <.001
Subtypes
STEMI

28.4 24.7 23.6 21.6 21.5 20.3 28.4 <.001
NSTEMI

5.4 11.0 13.3 14.6 17.3 19.8 266.5 <.001
Unspecified

0.9 2.3 5.7 5.0 4.9 4.5 389.3 <.001
Subtotal for female

34.7 38.0 42.6 41.1 43.7 44.7 28.5 <.001
Total
Crude rate 80.5 93.3 106.3 106.8 112.8 120.4 49.5 <.001
Age-standardized rate

55.8 62.2 69.3 68.0 70.0 73.3 31.2
NSTEMI¼ non-ST-segment elevation myocardial infarction; STEMI¼S
Age-standardized according to the 2000 Census population of Beijing.
FIGURE 1. Flow diagram for the selection of patients hospitalized
with AMI. AMI¼ acute myocardial infarction; HDIS¼hospital
discharge information system.
Zhang et al Medicine  Volume 95, Number 5, February 2016
4 | www.md-journal.comrisk factors in young and middle-aged adults and in elder age
groups of Beijing.14–16
Both a decrease in STEMI and increase in NSTEMI may
contribute to the transition in the pattern of AMI subtypes in a
population. The decrease in the STEMI hospitalization rate in
our population was consistent with the declining trend in most
Western populations.2–5,17 In contrast, based on data from 162
hospitals across China, the estimated national hospitalization
rate for STEMI increased from 3.5 in 2001 to 15.4 in 2011 per
100,000 people in the China PEACE study.18 More advanced
primary and secondary prevention of cardiovascular disease in
Beijing than in the rest of China may partly explain the
decreasing trend in STEMI in Beijing, which is similar to
the pattern in Western populations but differs from the national
status as found in the China PEACE study. The use of certain
cardioprotective medications (eg, statins, ACE inhibitors, beta-
blockers, and aspirin) reportedly may contribute to a lower risk
of presenting with STEMI.19 As a leading developed metropolis
in China, Beijing has made substantial improvement in the
treatment of AMI.20,21 Additionally, the awareness and treat-
ment of cardiovascular risk factors, such as dyslipidemia, are
more advanced in Beijing than in overall China,22,23 which may
contribute to the decreased STEMI in Beijing. On the other
T-segment elevation myocardial infarction.hand, the hospitalization rates for NSTEMI increased remark-
ably by three-fold in Beijing during the 6 years, unlike the mild
increases in Western populations.2,4,13,24 As a result, the overall
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
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STEMI. The increase in hospitalization rates for NSTEMI is
attributable to multiple causes. First, the use of highly sensi-
tive cardiac biomarkers, particularly troponin, may have
contributed to the increase in hospitalization for NSTEMI,
as observed in Western countries in the early 2000s.2,4,13
Cardiac troponins have been introduced for the diagnosis
of AMI in China since 2001 and widely available in urban
FIGURE 2. Proportion and the number of patients hospitalized fo
2012. NSTEMI¼non-ST-segment elevation myocardial infarction;cities in 2006.25 Moreover, previous studies reported that
implementation of troponin classified an additional 26% to
58% of patients as having AMI compared with traditional
FIGURE 3. Prevalence of comorbidities in patients hospitalized for S
infarction in Beijing, 2007 to 2012. NSTEMI¼non-ST-segment elevatio
infarction.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.enzymatic markers.26,27 Therefore, the use of troponins may not
solely explain the three-fold increase in NSTEMI. Another
possible reason for the increase inNSTEMIcould be the changing
characteristics of patients. Previous studies have observed that
advanced age and the presence of comorbidities are associated
with a higher probability of presentingwith NSTEMI.3,28 Similar
results were found in our study. Given the population aging and
increasing prevalence of cardiovascular risk factors in both the
ferent subtypes of acute myocardial infarction in Beijing, 2007 to
EMI¼ ST-segment elevation myocardial infarction.general population and patients with CHD,18,29,30 the hospital-
ization rates for NSTEMI are expected to continue increasing in
Beijing and the rest of China.
T-segment elevation and non-ST-segment elevation myocardial
nmyocardial infarction; STEMI¼ ST-segment elevationmyocardial
www.md-journal.com | 5
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Zhang et al Medicine  Volume 95, Number 5, February 2016We observed a declined trend in the AMI in-hospital
mortality in Beijing. The trends toward improved outcome of
AMI were also observed in some Western countries.31–33
Previous studies indicated that the outcomes of STEMI and
NSTEMI are distinct and vary by the type of intervention
received.3–5 Our study supports previous findings in that the
in-hospital mortality was significantly higher in patients with
STEMI than in those with NSTEMI. However, during the study
FIGURE 4. Use of revascularization in patients hospitalized for ST-se
in Beijing, 2007 to 2012. CABG¼ coronary artery bypass gra
PCI¼percutaneous coronary intervention; STEMI¼ST-segment elperiod, in-hospital mortality declined significantly for patients
with STEMI, particularly for those who underwent PCI, but the
outcome for patients with NSTEMI was not improved by the
FIGURE 5. Hospitalization rate of acute myocardial infarction in Beijin
infarction; STEMI¼ST-segment elevation myocardial infarction.
6 | www.md-journal.comtype of treatment received. Similarly, among patients with
STEMI in the United States, the improvement in in-hospital
mortality was statistically significant only for those who under-
went PCI; no improvement was observed for those who
received CABG or no intervention.5 Compared with STEMI,
patients with NSTEMI were less likely to undergo cardiac
catheterization or PCI during their hospitalization, and no
significant improvement in in-hospital mortality by type of
ent elevation and non-ST-segment elevationmyocardial infarction
g; NSTEMI¼non-ST-segment elevation myocardial infarction;
tion myocardial infarction.therapy was observed in our analysis. Evidence has demon-
strated that improvement in medical or intervention therapies
consistent with guidelines was associated with improvement in
g, 2007 to 2012. NSTEMI¼non-ST-segment elevation myocardial
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. In-Hospital Mortality (%) for Patients With Acute Myocardial Infarction (AMI) in Beijing, by Sex, Age, AMI Subtype, and
Type of Intervention, 2007 to 2012
2007 2008 2009 2010 2011 2012
Relative Change
2007–2012,% P for Trend
Male
Age groups, yr
<55 1.8 2.1 1.8 1.2 1.6 1.2 33.3 <.001
55–64 4.8 4.0 3.6 2.9 3.1 2.6 45.8 <.001
65–74 10.7 9.9 8.8 7.4 7.1 7.8 27.1 <.001
75–84 17.5 17.3 17.0 15.1 16.4 15.8 9.7 .13
85 30.3 34.3 31.8 28.9 29.8 24.3 19.8 .02
Subtypes

STEMI 9.0 8.8 7.3 5.8 6.5 6.6 26.7 <.001
STEMI with PCI 3.0 3.0 2.0 1.1 2.3 2.0 33.3 .01
STEMI with CABG 6.7 5.9 2.4 4.1 2.9 5.9 11.9 .53
STEMI without intervention 11.1 12.4 12.0 9.7 11.0 11.3 1.8 .20
NSTEMI 6.4 6.6 6.4 6.0 5.9 5.3 17.2 .02
NSTEMI with PCI 0.6 2.2 0.8 1.3 0.6 1.0 66.7 .70
NSTEMI with CABG 9.1 5.1 5.5 0.7 9.5 2.5 72.5 .54
NSTEMI without intervention 7.6 8.0 8.3 8.2 7.7 6.8 10.5 .08
Unspecified 13.7 15.3 14.9 14.1 15.5 14.8 8.0 .85
Subtotal for male

8.8 8.6 8.0 6.9 7.3 6.8 22.7 <.001
Female
Age groups, yr
<55 2.7 3.4 3.7 2.3 6.6 3.6 33.3 .23
55–64 7.8 6.4 4.6 5.6 3.8 4.0 48.7 .00
65–74 12.6 12.4 11.8 10.1 11.0 8.9 29.4 .00
75–84 22.3 19.4 19.5 15.4 17.5 16.8 24.7 .00
85 30.5 29.1 26.8 28.6 32.4 25.3 17.0 .47
Subtypes

STEMI 17.2 16.4 13.8 11.5 14.6 12.5 27.3 <.001
STEMI with PCI 7.3 3.3 5.2 5.6 5.1 5.3 27.4 .50
STEMI with CABG 19.4 6.0 6.7 0.0 14.1 9.6 50.5 .94
STEMI without intervention 19.7 20.9 18.0 15.6 20.7 17.1 13.2 .06
NSTEMI 11.6 9.1 10.6 10.2 10.0 8.7 25.0 .13
NSTEMI with PCI 3.0 3.2 0.7 2.1 0.9 1.6 46.7 .90
NSTEMI with CABG 0.0 8.3 4.5 21.1 3.0 12.9 NA .67
NSTEMI without intervention 13.4 10.2 12.8 11.8 12.1 10.5 21.6 .28
Unspecified 20.6 29.1 25.5 22.7 23.1 24.2 17.5 .80
Sub-total for female

16.3 14.9 14.3 12.4 13.8 12.1 25.8 <.001
Total
Crude rate 11.0 10.5 9.9 8.6 9.6 8.9 19.1 <.001
Age-standardized rate

11.2 10.7 10.1 8.6 9.4 8.6 23.2
CABG¼ coronary artery bypass grafting; NA¼ not applicable; NSTEMI¼ non-ST-segment elevation myocardial infarction; PCI¼ percutaneous
rctio
zed
Medicine  Volume 95, Number 5, February 2016 Recent Trends in Hospitalization for AMIin-hospital mortality for patients with NSTEMI.5,24,34 However,
a substantial gap in the in-hospital treatment for patients with
NSTEMI was also found in studies in Europe and the United
States.2,35,36Moreover, the long-termmortality for patients with
NSTEMI is reportedly worse than that for patients with STEMI
because the former are considerably older and have a higher
prevalence of cardiovascular comorbidities.2,35,36 These find-
ings, in line with ours, indicate that there is an urgent need to
improve the quality of care for patients with NSTEMI, a
condition that is on the rise.
coronary intervention; STEMI¼ST-segment elevation myocardial infa
Age-standardized according to the weights of all patients hospitaliThe LOS and hospitalization costs are valuable indicators
of health burden and allocation of resources. We observed that
the LOS for AMI declined by an average of 1 day over 6 years in
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.Beijing, but it remained longer than that in the United States and
Europe.37 Despite the decline in LOS, the in-hospital cost per
hospitalization for AMI increased by 3.2% in Beijing during the
6 years. Although there was a marked decline in the hospital-
ization cost for patients undergoing PCI and no intervention, the
decline was offset by the increased hospitalization costs in
patients undergoing CABG. Due to the increase in hospital
cost per hospitalization and the number of hospitalizations, the
aggregate hospital cost for AMI hospitalization reached 0.69
billion RMB (0.11 billion USD) at the city level in 2012,
n.
for AMI from 2007 to 2012, and by sex as needed.representing a 56.8% increase after adjusting for inflation
compared with 2007. The current governmental health insur-
ance system will face a substantial challenge if no effective
www.md-journal.com | 7
American acute myocardial infarction patients: findings from themeasure is taken to control the increase in total health expen-
diture associated with AMI hospitalization in Beijing.
This study has important implications. The rising hos-
pitalization rates and expenditures should encourage policy
makers to develop more cost-effective approaches for the
prevention and management of AMI. From the clinical
perspective, the transition from STEMI to NSTEMI empha-
sized the necessity of improving the treatment of patients with
NSTEMI and the management of cardiovascular comorbid-
ities. This study involved a large, unselected population from
a megacity characterized by rapid socioeconomic develop-
ment and transition in the pattern of disease, which may
indicate coming trends in other cities in China and other
developing countries.
Our findings should be interpreted with caution because of
several limitations. First, the current analysis was based on the
routinely collected data in the HDIS. The quality of hospital
discharge data regarding the diagnosis of AMI has not been
validated in China before. Our validation study is the first to
show that hospital discharge data are reliable regarding the
diagnosis of AMI and the differentiation of AMI subtypes.
However, given the large sample size, the validation was
conducted only for a sample of 1736 patients selected by using
stratified sampling method. Second, military hospitals are not
covered by the Beijing HDIS. However, the number of local
patients with AMI admitted to military hospitals is likely to be
small and stable; thus, their exclusion was unlikely to alter the
current trends, although the hospitalization rates would be
somewhat underestimated. Besides, information onmedications
provided during hospitalization are not available in Beijing
HDIS, thus precluding the assessment of thrombolysis, as
reported by previous studies using hospital discharge data.38
In conclusion, the hospitalization rates of AMI increased
significantly in Beijing from 2007 to 2012 with a transition from
STEMI to NSTEMI. In-hospital mortality and LOS decreased,
whereas per-hospitalization and total in-hospital costs increased
steadily. Findings from these unselected ‘‘real-world’’ data in
Beijing may help to guide the management of AMI in China and
other developing countries.
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